NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation
Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

NCT07354217

Not Yet RecruitingPhase 4

Sponsor: National Taiwan University Hospital

Conditions: Pulsed Field Ablation, Lidocaine

Interventions: lidocaine, Saline

Countries: Taiwan

To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

1. Patients with paroxysmal or persistent AF and are scheduled to undergo PVI.
2. Patients who can understand the study aims and protocol and are willing to follow the protocol for one year.

Exclusion Criteria:

1. Informed consent could not be obtained
2. Known allergy to study drug lidocaine.
3. Presence of thrombus in the LA or LA appendage
4. Underlying significant pulmonary disease, such as asthma or COPD needing long term maintenance therapy or documented interstitial lung disease
Locations (1)
  • Taipei, Taiwan